Αποτελέσματα Αναζήτησης
Inovio Pharmaceuticals Inc Stock (INO) is expected to reach an average price of $29.24 in 2030, with a high forecast of $40.15 and a low forecast of $18.33. This signifies an +415.73% surge from the last price of $5.67.
Stock Price Forecast. The 6 analysts with 12-month price forecasts for INO stock have an average target of 21.17, with a low estimate of 7.00 and a high estimate of 40. The average target predicts an increase of 277.36% from the current stock price of 5.61. Analyst Consensus: Buy. Analyst Ratings.
4 ημέρες πριν · According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Inovio Pharmaceuticals is $43.80, with a high forecast of $144.00 and a low forecast of $7.00.
Inovio Pharmaceuticals is forecast to grow earnings and revenue by 36.4% and 75.8% per annum respectively while EPS is expected to grow by 43.9% per annum. Key information. 36.4% Earnings growth rate. n/a. EPS growth rate. Recent future growth updates. Consensus revenue estimates fall by 16% Aug 14. Price target decreased by 11% to US$16.75. Aug 12
Assess the Inovio stock price estimates. View analyst opinion as to whether the stock is a strong buy, strong sell or hold, based on analyst 12-Month INO price targets.
12 Φεβ 2020 · Analyst Forecast. According to 6 analysts, the average rating for INO stock is "Buy." The 12-month stock price forecast is $21.17, which is an increase of 280.76% from the latest price.
Inovio Pharmaceuticals Inc (INO) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus.
